title: What is new in gynecologic oncology? Thought-provoking articles from the past year.
authors: University of Pecs, Pecs, Hungary.
authors: Ioannis
authors: I
authors: Hatzipetros
authors: Istvan
authors: I
authors: Drozgyik
authors: Jozsef
authors: J
authors: Bodis
mesh_terms: D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans
references: Modesitt SC. What is new in gynecologic oncology? Thought-provoking articles from the past year. Obstet Gynecol 2013;121:872–3.
references: Maggino T, Gaducci A, D’Addario V, Pecorelli S, Lissoni A, Stella M, et al.. Prospective multicenter study on CA 125 in postmenopausal pelvic masses. Gynecol Oncol 1994;54:117–23.
references: Ma S, Shen K, Lang J. A risk of malignancy index in preoperative diagnosis of ovarian cancer. Chin Med J 2003;116:396–9.
references: Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod 1989;4:1–12.
references: Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al.. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 2009;112:40–6.
references: Hellstrom I, Hellstrom KE. SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other. Adv Exp Med Biol 2008;622:15–21.